PMID- 28817869
OWN - NLM
STAT- MEDLINE
DCOM- 20190314
LR  - 20190314
IS  - 1527-3792 (Electronic)
IS  - 0022-5347 (Linking)
VI  - 198
IP  - 3
DP  - 2017 Sep
TI  - Re: Impact of Combination Therapy 5-Alpha Reductase Inhibitors (5-ARI) plus
      Alpha-Blockers (AB) on Erectile Dysfunction and Decrease of Libido in Patients
      with LUTS/BPH: A Systematic Review with Meta-Analysis.
PG  - 457-458
LID - S0022-5347(17)74812-4 [pii]
LID - 10.1016/j.juro.2017.06.030 [doi]
FAU - Kaplan, Steven A
AU  - Kaplan SA
LA  - eng
PT  - Journal Article
PT  - Comment
DEP - 20170620
PL  - United States
TA  - J Urol
JT  - The Journal of urology
JID - 0376374
RN  - 0 (5-alpha Reductase Inhibitors)
RN  - 0 (Adrenergic alpha-Antagonists)
SB  - AIM
SB  - IM
CON - Aging Male. 2016 Sep;19(3):175-181. PMID: 27310433
MH  - 5-alpha Reductase Inhibitors
MH  - Adrenergic alpha-Antagonists
MH  - *Erectile Dysfunction
MH  - Humans
MH  - Libido
MH  - Male
MH  - *Prostatic Hyperplasia
EDAT- 2017/08/19 06:00
MHDA- 2019/03/15 06:00
CRDT- 2017/08/19 06:00
PHST- 2017/08/19 06:00 [entrez]
PHST- 2017/08/19 06:00 [pubmed]
PHST- 2019/03/15 06:00 [medline]
AID - S0022-5347(17)74812-4 [pii]
AID - 10.1016/j.juro.2017.06.030 [doi]
PST - ppublish
SO  - J Urol. 2017 Sep;198(3):457-458. doi: 10.1016/j.juro.2017.06.030. Epub 2017 Jun
      20.